Sumaylo, Nasra Astrid Q.
HRN: 21-32-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/14/2022
IVY
220mg
Q8
Pcap C , Age With Mod Dhn, G6pd
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes